Lifetime Data Analysis

, Volume 18, Issue 2, pp 139–156 | Cite as

A parametric model fitting time to first event for overdispersed data: application to time to relapse in multiple sclerosis

Article

Abstract

In this article, we propose a parametric model for the distribution of time to first event when events are overdispersed and can be properly fitted by a Negative Binomial distribution. This is a very common situation in medical statistics, when the occurrence of events is summarized as a count for each patient and the simple Poisson model is not adequate to account for overdispersion of data. In this situation, studying the time of occurrence of the first event can be of interest. From the Negative Binomial distribution of counts, we derive a new parametric model for time to first event and apply it to fit the distribution of time to first relapse in multiple sclerosis (MS). We develop the regression model with methods for covariate estimation. We show that, as the Negative Binomial model properly fits relapse counts data, this new model matches quite perfectly the distribution of time to first relapse, as tested in two large datasets of MS patients. Finally we compare its performance, when fitting time to first relapse in MS, with other models widely used in survival analysis (the semiparametric Cox model and the parametric exponential, Weibull, log-logistic and log-normal models).

Keywords

Mixed Poisson processes Multiple sclerosis relapses Negative binomial distribution Recurrent events Time to event 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albrecht P (1982) Zur statistischen Analyse des gemischten Poissonprozesses, gestützt auf Schadeneintrittszeitpunkte. Blä Dtsch Ges Versich-math 15: 249–257MATHGoogle Scholar
  2. Anders S, Huber W (2010) Differential expression analysis for sequence count data. Genome Biol 11: R106CrossRefGoogle Scholar
  3. Asmussen S (2003) Applied probability and queues. Springer, New YorkMATHGoogle Scholar
  4. Cook RJ, Lawless JF (2003) The statistical analysis of recurrent events. Statistics for biology and health series. Springer, New YorkGoogle Scholar
  5. Embrechts P, Klüppelberg C, Mikosh T (1997) Modelling extremal events for insurance and Finance. Springer, New YorkMATHGoogle Scholar
  6. Fekedulegn D, Andrew M, Violanti J, Hartley T, Charles L, Burchfiel C (2010) Comparison of statistical approaches to evaluate factors associated with metabolic syndrome. J Clin Hypertens 12: 365–373CrossRefGoogle Scholar
  7. Ferreri C (1982) On the extended Pólya process and some its interpretations. Metron 41: 11–27MathSciNetGoogle Scholar
  8. Glynn R, Stukel TA, Sharp SA, Bubolz A, Freeman JL, Fisher ES (1993) Estimating the variance of standardized rates of recurrent events, with application to hospitalizations among the elderly in New England. Am J Epidemiol 137: 776–786Google Scholar
  9. Grandell J (1997) Mixed poisson processes. Cambridge University Press, CambridgeMATHGoogle Scholar
  10. Hilbe J (2011) Negative binomial regression. Chapman and Hall, LondonMATHGoogle Scholar
  11. Mikosch T (2004) Non-life insurance mathematics an introduction with stochastic processes. Springer, HeidelbergMATHGoogle Scholar
  12. PRISMS (Prevention of Relapses and disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group (1998) Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet 352:1498–1504Google Scholar
  13. Ross SM (2010) Inroduction to probability models, 10th edn. Academic Press, San DiegoGoogle Scholar
  14. Sormani MP, Bruzzi P, Miller DH, Gasperini C, Barkhof F, Filippi M (1999) Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials. J Neurol Sci 163: 74–80CrossRefGoogle Scholar
  15. Sormani MP, Bruzzi P, Rovaris M, Barkhof F, Comi G, Miller DH, Cutter GR, Filippi M (2001a) Modelling new enhancing MRI lesion counts in multiple sclerosis. Mult Scler 7: 298–304Google Scholar
  16. Sormani MP, Miller DH, Comi G, Barkhof F, Rovaris M, Bruzzi P, Filippi M (2001b) Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets. J Neurol Neurosurg Psychiatry 70: 494–499CrossRefGoogle Scholar
  17. SPECTRIMS (Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon beta-1a in MS) Study Group (2001) Randomized controlled trial of interferon beta-1a in secondary progressive MS: clinical results. Neurology 56:1496–1504Google Scholar
  18. Vanden Elskamp I, Knol D, Uitdehaag B, Barkhof F (2009) The distribution of new enhancing lesion counts in multiple sclerosis: further explorations. Mult Scler 15: 42–49CrossRefGoogle Scholar
  19. Wang YC, Meyerson L, Tang YQ, Qian N (2009) Statistical methods for the analysis of relapse data in MS clinical trials. J Neurol Sci 285: 206–211CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Paola Siri
    • 1
  • Eric Henninger
    • 2
  • Maria Pia Sormani
    • 3
  1. 1.Department of Mathematics (DIMAT)Polytechnic of TurinTorinoItaly
  2. 2.Merck Serono S.A.GenevaSwitzerland
  3. 3.Biostatistics Unit, Department of Health Sciences (DISSAL)University of GenovaGenovaItaly

Personalised recommendations